Warning! GuruFocus detected
1 Severe warning sign
with PDSB.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
PDS Biotechnology Corp (NAS:PDSB) Stock News, Headlines & Updates
PDS Biotechnology Corp Stock News from GuruFocus
- 1
Apr 25, 2025
PDS Biotechnology (PDSB) Price Target Cut by B. Riley Amid Strategic Focus Shift | PDSB Stock News
GuruFocus News • 8:01am
Apr 23, 2025
PDS Biotech Announces Multiple Abstracts Selected for Presentation at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting
Marketwired • 10:00am
PDS Biotech Announces Multiple Abstracts Selected for Presentation at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting | PDSB Stock News
GuruFocus News • 9:30am
Apr 16, 2025
PDS Biotech Announces Preclinical Influenza Data to be Presented in Symposium at IMMUNOLOGY2025â„¢ Annual Meeting
Marketwired • 7:00am
Apr 08, 2025
PDS Biotech Announces PDS01ADC Clinical Data to be Presented at the American Association for Cancer Research (AACR) Annual Meeting 2025
Marketwired • 8:00am
Mar 28, 2025
PDS Biotechnology Corp (PDSB) Q4 2024 Earnings Call Highlights: Strategic Advances Amid Financial Challenges
GuruFocus News • 1:01am
Q4 2024 PDS Biotechnology Corp Earnings Call Transcript
GuruFocus News • 11:03pm
Mar 27, 2025
PDS Biotechnology (PDSB) Posts Earnings Beat, Reports Strong Cash Position
GuruFocus News • 5:10pm
PDS Biotech Reports Full Year 2024 Financial Results and Provides Clinical Programs Update
Marketwired • 7:00am
Mar 25, 2025
PDS Biotech Leadership to Present at 2025 CAGLA NeauxCancer Conference
Marketwired • 8:00am
Mar 18, 2025
PDS Biotech Announces Conference Call and Webcast for Full Year 2024 Financial Results
Marketwired • 7:00am
Mar 13, 2025
PDS Biotech Announces FDA Clearance of IND Application for Combination of Versamune® MUC1 and PDS01ADC to Treat Metastatic Colorectal Cancer
Marketwired • 7:00am
Mar 11, 2025
PDS Biotech Leadership to Participate in March Conferences
Marketwired • 7:00am
Mar 07, 2025
PDS Biotech Initiates VERSATILE-003 Phase 3 Clinical Trial Evaluating Versamune® HPV in HPV16-Positive Head and Neck Cancer
Marketwired • 8:00am
Mar 04, 2025
Insider Buying: Stephen Glover Acquires Additional Shares of PDS Biotechnology Corp (PDSB)
GuruFocus News • 6:01pm
Insider Buying: Gregory Freitag Acquires Additional Shares of PDS Biotechnology Corp
GuruFocus News • 6:01pm
Feb 27, 2025
PDS Biotech Announces up to $22 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Marketwired • 7:00am
Feb 26, 2025
PDS Biotech Announces Positive Clinical Data Demonstrating Compelling Survival and Clinical Responses in Recurrent/Metastatic HPV-Associated Cancers Published in JAMA Oncology
Marketwired • 7:00am
Feb 24, 2025
PDS Biotech Announces Circulating Tumor DNA Results for Versamune® HPV in IMMUNOCERV Trial Published in Clinical Cancer Research
Marketwired • 7:00am
Feb 20, 2025
PDS Biotech to Participate at B. Riley Securities Precision Oncology & Radiopharma Conference 2025
Marketwired • 7:00am
Feb 05, 2025
- 1
Show
Entries
Headlines
Total 0- 1
No recent news